Preventable Infant Deaths Rise as Parents Skip Vitamin K Shots

Context In the United States, a growing number of families refuse the vitamin K prophylaxis given shortly after delivery, citing concerns about unnecessary medical interventions. Social media amplifies misinformation that frames the shot as risky, despite decades of safety data. Consequently, clinicians are seeing a resurgence of vitamin K deficiency bleeding (VKDB), a disorder that can cause severe intracranial or gastrointestinal hemorrhage in newborns.

Key Facts Autopsies of several infants who died in the last few years revealed bleeding patterns typical of VKDB, including intracranial hemorrhages and umbilical‑cord site bleeding. A 7‑week‑old boy in Maryland presented with sudden seizures before death, consistent with late‑onset VKDB. Research shows that a single intramuscular dose of vitamin K1 at birth prevents classic and late VKDB in over 99 % of cases. A 1993 randomized controlled trial involving 2,400 newborns demonstrated a 95 % reduction in bleeding events compared with placebo (p < 0.001). A 2016 meta‑analysis of five cohort studies encompassing more than 150,000 infants confirmed the shot’s effectiveness and found no increase in adverse reactions. Importantly, the association between shot refusal and VKDB is causal: the deficiency directly impairs clotting factor synthesis, leading to hemorrhage when vitamin K is absent.

What It Means Parents who decline the shot expose their newborns to a preventable risk that can result in death or lifelong neurological damage. The injection costs less than one dollar, carries minimal side effects, and is endorsed by the American Academy of Pediatrics and the World Health Organization. Public health officials stress that improving communication about the shot’s safety and necessity is essential to reverse the trend. Health systems should consider opt‑out policies with clear, evidence‑based counseling to protect infants.

What to watch next: state legislatures are reviewing bills that would make vitamin K prophylaxis mandatory unless a medical contraindication exists, and upcoming CDC surveillance data will show whether refusal rates continue to climb.